SurgePays Statistics Share Statistics SurgePays has 20.41M
shares outstanding. The number of shares has increased by 3.38%
in one year.
Shares Outstanding 20.41M Shares Change (YoY) 3.38% Shares Change (QoQ) 0% Owned by Institutions (%) 9.3% Shares Floating 13.99M Failed to Deliver (FTD) Shares 3,294 FTD / Avg. Volume 2.48%
Short Selling Information The latest short interest is 184.8K, so 0.91% of the outstanding
shares have been sold short.
Short Interest 184.8K Short % of Shares Out 0.91% Short % of Float 1.3% Short Ratio (days to cover) 2.76
Valuation Ratios The PE ratio is -0.74 and the forward
PE ratio is 2.18.
SurgePays's PEG ratio is
0.
PE Ratio -0.74 Forward PE 2.18 PS Ratio 0.56 Forward PS 0.3 PB Ratio 2.22 P/FCF Ratio -1.56 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for SurgePays.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.95,
with a Debt / Equity ratio of 0.3.
Current Ratio 2.95 Quick Ratio 2.66 Debt / Equity 0.3 Debt / EBITDA -0.11 Debt / FCF -0.21 Interest Coverage -75.39
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $468.32K Profits Per Employee $-351.76K Employee Count 130 Asset Turnover 2.54 Inventory Turnover 42.22
Taxes Income Tax 2.87M Effective Tax Rate -6.66%
Stock Price Statistics The stock price has increased by 8.68% in the
last 52 weeks. The beta is 1.09, so SurgePays's
price volatility has been higher than the market average.
Beta 1.09 52-Week Price Change 8.68% 50-Day Moving Average 2.93 200-Day Moving Average 2.16 Relative Strength Index (RSI) 50.45 Average Volume (20 Days) 132,672
Income Statement In the last 12 months, SurgePays had revenue of 60.88M
and earned -45.73M
in profits. Earnings per share was -2.39.
Revenue 60.88M Gross Profit -14.32M Operating Income -41.78M Net Income -45.73M EBITDA -41.22M EBIT -42.51M Earnings Per Share (EPS) -2.39
Full Income Statement Balance Sheet The company has 11.79M in cash and 4.59M in
debt, giving a net cash position of 7.2M.
Cash & Cash Equivalents 11.79M Total Debt 4.59M Net Cash 7.2M Retained Earnings -60.92M Total Assets 15.66M Working Capital 4.11M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -21.31M
and capital expenditures -518.19K, giving a free cash flow of -21.83M.
Operating Cash Flow -21.31M Capital Expenditures -518.19K Free Cash Flow -21.83M FCF Per Share -1.14
Full Cash Flow Statement Margins Gross margin is -23.53%, with operating and profit margins of -68.63% and -75.11%.
Gross Margin -23.53% Operating Margin -68.63% Pretax Margin -70.74% Profit Margin -75.11% EBITDA Margin -67.71% EBIT Margin -68.63% FCF Margin -35.85%
Dividends & Yields SURG does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for SURG is $9,
which is 212.5% higher than the current price. The consensus rating is "Strong Buy".
Price Target $9 Price Target Difference 212.5% Analyst Consensus Strong Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 2, 2021. It was a
backward
split with a ratio of 1:50.
Last Split Date Nov 2, 2021 Split Type backward Split Ratio 1:50
Scores Altman Z-Score -9.69 Piotroski F-Score 2
